Related Experiment Video

Updated: Aug 20, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Regulatory expectations during product development for tumour vaccines

K Kawakami1, R K Puri

  • 1Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, CBER, FDA, Bethesda, MD 20892, USA. kawakami@cber.fda.gov

Developments in Biologicals
|December 18, 2004
PubMed

Insights

Therapeutic tumor vaccines harness the immune system to fight cancer. This review covers regulatory considerations for various vaccine types, emphasizing manufacturing and characterization during development.

Area of Science:

  • Immunology
  • Oncology
  • Regulatory Science

Background:

  • Tumor vaccines stimulate host immunity against cancer, potentially causing tumor regression.
  • Therapeutic tumor vaccines encompass cellular vaccines, peptides, proteins, and antigen preparations.
  • Despite ongoing clinical trials, no tumor vaccines are currently FDA-approved.

Purpose of the Study:

  • To summarize regulatory issues for different tumor vaccine types.
  • To discuss the step-wise approach to regulatory requirements for vaccine development.
  • To highlight the importance of current good manufacturing practices (cGMPs) and characterization.

Main Methods:

  • Review of regulatory landscape for therapeutic tumor vaccines.
  • Discussion of product development stages and associated requirements.
  • Emphasis on cGMPs and vaccine characterization.

Main Results:

  • No FDA-licensed tumor vaccines exist, but many are in development.
  • Regulatory pathways vary depending on vaccine type.
  • cGMPs and robust characterization are critical throughout development.

Conclusions:

  • Navigating regulatory requirements is essential for advancing tumor vaccine development.
  • Standardized approaches to manufacturing and characterization are needed.
  • Continued research and clinical trials are crucial for future approvals.

More Related Videos

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor06:18

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on: August 18, 2023

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...